GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Thalys Medical Technology Group Corp (SHSE:603716) » Definitions » EV-to-FCF

Thalys Medical Technology Group (SHSE:603716) EV-to-FCF : -409.53 (As of Mar. 27, 2025)


View and export this data going back to 2016. Start your Free Trial

What is Thalys Medical Technology Group EV-to-FCF?

EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Thalys Medical Technology Group's Enterprise Value is ¥3,119 Mil. Thalys Medical Technology Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-8 Mil. Therefore, Thalys Medical Technology Group's EV-to-FCF for today is -409.53.

The historical rank and industry rank for Thalys Medical Technology Group's EV-to-FCF or its related term are showing as below:

SHSE:603716' s EV-to-FCF Range Over the Past 10 Years
Min: -1728.39   Med: -24.64   Max: 483.22
Current: -461.95

During the past 13 years, the highest EV-to-FCF of Thalys Medical Technology Group was 483.22. The lowest was -1728.39. And the median was -24.64.

SHSE:603716's EV-to-FCF is ranked worse than
100% of 106 companies
in the Medical Diagnostics & Research industry
Industry Median: 26.475 vs SHSE:603716: -461.95

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

As of today (2025-03-27), Thalys Medical Technology Group's stock price is ¥11.33. Thalys Medical Technology Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 was ¥-1.079. Therefore, Thalys Medical Technology Group's PE Ratio (TTM) for today is At Loss.


Thalys Medical Technology Group EV-to-FCF Historical Data

The historical data trend for Thalys Medical Technology Group's EV-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Thalys Medical Technology Group EV-to-FCF Chart

Thalys Medical Technology Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,545.24 -36.61 -22.03 -127.54 36.65

Thalys Medical Technology Group Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
EV-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -169.66 36.65 134.13 -28.46 -313.11

Competitive Comparison of Thalys Medical Technology Group's EV-to-FCF

For the Diagnostics & Research subindustry, Thalys Medical Technology Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Thalys Medical Technology Group's EV-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Thalys Medical Technology Group's EV-to-FCF distribution charts can be found below:

* The bar in red indicates where Thalys Medical Technology Group's EV-to-FCF falls into.


;
;

Thalys Medical Technology Group EV-to-FCF Calculation

Thalys Medical Technology Group's EV-to-FCF for today is calculated as:

EV-to-FCF=Enterprise Value (Today)/Free Cash Flow (TTM)
=3119.015/-7.616
=-409.53

Thalys Medical Technology Group's current Enterprise Value is ¥3,119 Mil.
Thalys Medical Technology Group's Free Cash Flow for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-8 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Thalys Medical Technology Group  (SHSE:603716) EV-to-FCF Explanation

EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.

Thalys Medical Technology Group's PE Ratio (TTM) for today is calculated as:

PE Ratio (TTM)=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=11.33/-1.079
=At Loss

Thalys Medical Technology Group's share price for today is ¥11.33.
Thalys Medical Technology Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-1.079.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.


Thalys Medical Technology Group EV-to-FCF Related Terms

Thank you for viewing the detailed overview of Thalys Medical Technology Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Thalys Medical Technology Group Business Description

Traded in Other Exchanges
N/A
Address
1310 Jinshan Avenue, Dongxihu District, Hubei Province, Wuhan, CHN, 430040
Thalys Medical Technology Group Corp is engaged in intensive sales business, pure sales, and research and development, production and sales of independent in vitro diagnostic products.
Executives
Wang Jun Ming senior management
Wang Zheng senior management
Wang Wen Bin senior management
Liu Wen Hao Director
Huang Yong Xi senior management
Lei Xian Kun Director
Fan Li Director
Liu Yuan senior management
Wan Li Bo senior management
Wen Wei Director
Chou Jian senior management
Song Yu Director

Thalys Medical Technology Group Headlines

No Headlines